We take the privilege of hosting International Hypertension meetings worldwide and very excited to expand to USA. With the valuable support of Scientific Committee Members, International Conference on Hypertension & Cardiology planned to be held in the beautiful Las Vegas, USA during September 3-4, 2018.
Working under the theme “Control Hypertension: Add life to Longevity” we bring together a unique international mix of large and medium medical and clinical research and diagnostic companies, leading universities and medical research institutions. This is a perfect platform to share experience, foster collaborations across industry and academia and evaluate emerging innovations around the world. This conference mainly focuses on spreading the awareness about challenges in this field and how to prevent and manage hypertension and other cardiovascular diseases.
Meetings International through its Open Access Initiative is committed to create real and reliable contributions to the scientific community. Meetings Internationals organize 150+ Conferences once a year across USA, Europe & Asia with support from a thousand additional scientific societies and Publishes 150+ Open access journals that contains over 10000 eminent personalities, putative scientists as editorial board members.
Hypertension Conference Highlights:
We invite all Doctors, Scientists, Research Scholar, Heads, Deans and Professors of Hypertension or Cardiology departments, Nutraceutical industry, and Healthcare companies, Entrepreneurs, R&D Institutes, Healthcare Innovators, Public Health Professionals, Clinical Researchers, Life Science Investors, Druggists, Diabetes Societies and Associations, Academic Researchers.
Hypertension Conference will influence an attractive moment to meet people in the experimentation field and therefore it takes a pleasure in opening a doorway to encounter the ability in the field, young researchers and potential World-renowned speakers, the most recent approaches, tactics, and the current upgrade in the field of Cardiology.
Meetings International of Hypertension Conference will offer you an unmatched attendee experience. In addition to the many scientific sessions and take-home case study examples, you will leave this event with many other evidence based practice from some of our workshops and symposiums. We hope you will join us in Las Vegas in September.
Hypertension, also called high blood pressure is a long term medical condition in which the blood pressure in the arteries is frequently elevated. High blood pressure usually does not cause symptoms. Long term high blood pressure is a main risk factor for coronary artery disease, stroke, heart failure, peripheral vascular disease, vision loss, and chronic kidney disease. It is classified as either primary (essential) high blood pressure or secondary high blood pressure. About 90–95% of cases are primary hypertension, caused due to nonspecific lifestyle and genetic factors.
Hypertension Conference is covering with the topics are Secondary Hypertension, Hypertension Rheumatoid Arthritis, Oncology and Blood Pressure, Genetic Factors of Hypertension, Life Style of High Blood Pressure.
Hypertension can lead to many complications of Diabetes. Most people affected with Diabetes are more prone to suffer Hypertension. Diabetes damages the arteries and makes them targets for hardening (also called as atherosclerosis) and if it is not treated then it may also cause blood vessel damage, heart attack, and kidney failure too. In this section of the main we discuss about various types of Diabetes, risk factors that are involved into it, controlling hypertension in patients with Diabetes and Treatment.
Stressful situations can lead the blood to spike up temporarily but sometimes it may cause high blood pressure too. Research is still in progress to find out about it. According to some reports the change in the blood pressure behavior can be due to various habits like overeating, drinking or poor sleeping. It’s possible that health conditions related to stress like anxiety, depression and isolation from friends and family may lead to a heart disease but not to a high blood pressure condition. Some hormonal changes may damage your arteries leading towards heart disease.
Hypertension, Stroke & Obesity Event is covering the sub tracks are Incidence of Hypertension and Obesity, Pathophysiology of Obesity-related Hypertension, Interaction of Obesity with Consequences of Hypertension, Prevention & Management of weight gain and Hypertension,Therapies to Treat Obesity-related Hypertension
The investigations have showed that children in the highest quartile of BP had significantly narrower retinal arterioles than those with lower BP, suggesting that higher BP in childhood is associated with alteration in the microvasculature. There is even emerging evidence that cognitive function is adversely affected by elevated blood pressure in childhood. This session includes the epidemiology, incidence and pathophysiology of pediatric hypertension related with obesity, along with the cardiovascular risk factors, the onset of hypertension and obesity on children and the treatment and management of pediatric Hypertension and Obesity.
Pediatric Hypertension expo is contributing the topics are Epidemiology of Obesity Hypertension in Children, Incidence of Hypertension in Childhood, Pathophysiology of Paediatric Hypertension & Obesity, Cardiovascular Risk Factors & Complications, Outcomes of Childhood onset Hypertension due to Obesity, Treatment and Management
Reno vascular hypertension (RVHT) reflects the causal relation between anatomically evident arterial occlusive disease and elevated blood pressure. The coexistence of renal arterial vascular disease and hypertension roughly defines this type of nonessential hypertension. More specific diagnoses are made retrospectively when hypertension improves after intravascular intervention. At present, no sufficiently accurate, non-invasive, radiologic, or serologic screening test is available that, if negative, completely excludes the presence of renal artery stenosis (RAS).
Renal Hypertension Conference is going to give the subject are Indications and Symptoms of Renal Hypertension, Pathogenesis of Renal Hypertension., Diagnosis & Treatment, Risk Factors for Renal Hypertension, Renal-artery Angioplasty and Stenting
Pulmonary hypertension (PH) is a rise of blood pressure within the artery, vein, or respiratory organ capillaries, resulting in shortness of breath, dizziness, fainting, leg swelling and different symptoms. This type of hypertension that affects the arteries in the lungs and the right side of your heart, then it begin when tiny arteries in your lungs, called pulmonary arteries, and capillaries become narrowed, blocked or destroyed. This makes it harder for blood to flow through your lungs, and raises pressure within your lungs' arteries.
Pulmonary Hypertension Symposium connecting with the topics are Sign, Symptoms and Causes of PH, Genetics and Molecular Pathology, Pulmonary Embolism, Treatment and Therapies, Asthma and Allergy
Gestational hypertension or pregnancy-induced hypertension (PIH) is the development of new hypertension in a pregnant woman after 20 weeks gestation without the presence of protein in the urine or other signs of Pre-eclampsia in pregnancy. It is a temporary diagnosis for hypertensive pregnant women who do not meet criteria for preeclampsia or chronic hypertension (hypertension first detected before the 20th week of pregnancy). The diagnosis is changed to, Preeclampsia, if proteinuria or new signs of end-organ dysfunction develop and chronic (primary or secondary) hypertension, if blood pressure elevation persists ≥12 weeks postpartum.
Gestational Hypertension Workshop related to the subjects are Classification of Pregnancy Induced Hypertension, Risk factors for Gestational Hypertension, Pre-eclampsia and Eclampsia, Pathogenesis of Pre-Eclampsia, Management of Hypertension in Pregnancy, Drug Treatment of Gestational Hypertension, Long Term Cardiovascular Sequelae of Gestational Hypertension
Heart disease describes a range of conditions that affect the heart. Diseases under the heart includes blood vessel diseases, such as coronary artery disease; heart rhythm problems (arrhythmias); and heart defects you're born with (congenital heart defects), among others. Heart disease term is often used interchangeably with the cardiovascular disease. It generally refers to conditions that involve narrowed or blocked blood vessels that can lead to a heart attack, chest pain (angina) or stroke. Other heart conditions, such as those that affect your heart's muscle, valves or rhythm, also are considered of heart disease. Many forms of heart disease can be prevented or treated with healthy lifestyle choices.
Hypertension & Heart Disease Meeting has the highlights of Hypertension and Tachycardia, Structural Heart Disease, Transient Ischemic Attack, Risk Factor for Fatal and Nonfatal Cardiovascular Disease, Cardiovascular Medicine Research, New Theories of Diagnosis of the Blood Vessels, Cardio Metabolic Diseases Management, Cardiac Rehabilitation, Cardiac Catheterizations and Electrophysiology Studies
Cardiovascular disease represents the leading cause of morbidity and mortality in Western countries, and hypertension-related cardiovascular events or hypertensive emergencies affect about 37 million people per year, worldwide. In this perspective, hypertensive patients are at increased risk to experience cardiovascular events during life-long period, and treatment of high blood pressure represents one of the most effective strategies to reduce global cardiovascular risk.
Hypertension Risk Factors Conference providing related topics are Controllable Risk Factors, Uncontrollable Risk Factors, Medical Risk Factors, Other Factors
Blood pressure is determined by the cardiac output balanced against systemic vascular resistance. The process of maintaining blood pressure is complex, and involves numerous physiological mechanisms, including arterial baroreceptors, the renin–angiotensin–aldosterone system, atrial natriuretic peptide, endothelins, and mineralocorticoid and glucocorticoid steroids.
Hypertension Diagnosis Expo is having the sub topics are Hypertension Differential Diagnosis, Differential Diagnosis I: Primary Hypertension, Differential Diagnosis I: Primary Hypertension, Differential Diagnosis III: Complicated Hypertension
Family physicians coordinate the natural, clinical, and behavioural sciences to give proceeding with and comprehensive health care. Unlike paediatricians, who basically offer thought to children, and internists, who simply offer thought to adults, family medication incorporates all ages, genders, every organ framework, and every disease entity. Family doctors moreover give vigilant thought to their patients' within the context of family and the group.
Medications to treat high blood pressure includes Thiazide diuretics, Beta blockers, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers (ARBs), Calcium channel blockers and Renin inhibitors. Additional medication sometimes used to treat high blood pressure comprises Alpha blockers, Alpha-beta blockers, Central-acting agents, Vasodilators and Aldosterone antagonists.
Pharmacological Treatments for Hypertension Congress has the related topics are Medications to Treat High Blood Pressure, Lifestyle Changes to treat high Blood Pressure, Complementary and Alternative Treatment for Hypertension, Pharmacological Management of Hypertension, Follow-up Care for Hypertension
Nursing service administration is a coordinated activity, which provides all the facilities necessary for the rendering of nursing service to clients. Nursing service administration is the system of activities directed toward the nursing care of clients, and includes Nursing Leadership and Management the establishment of over-all goals and policies within the aims of the health agency and provision of organization, personnel, and facilities to accomplish this goals in the most effective and economical manner through cooperative efforts of all members of the staff, coordinating the service with other departments of the institution.
Nursing Management of Hypertension Meeting covering the subjects are Opportunity to Assess BP Detection, Educate Clients on Their Target BP, Importance of Achieving and Maintaining Target, Frequent Error in Clinic-Based BP Assessment, Patient Preparation and Posture, Recommended Technique for Measuring Blood Pressure, Threshold for Initiation of Treatment and Target Values
Hypertension is a powerful risk factor for fatal and nonfatal cardiovascular disease events. Data from observational studies indicate that this risk is continuous, without evidence of a threshold, down to blood pressures as low as 115/75 mm Hg. Randomized controlled trials have convincingly shown that treatment of hypertension reduces the risk of stroke, coronary heart disease, congestive heart failure, and mortality. Various studies of hypertension control have been performed in a variety of epidemiological and practice settings.
Hypertension Epidemiology Symposium is giving the related areas are Hypertension Incidence, Hypertension in Adults, Hypertension in Children, Healthcare Costs for Hypertension
Traditional medicine originated and has evolved over thousands of years. Traditional Medicine is a system of primary health care that includes acupuncture Chinese herbal medicine, remedial massage, exercise and breathing therapy and diet and lifestyle advice. In Australia, the most popular forms of TCM health care are acupuncture and Herbal Medicine. It has an uninterrupted history of development in China and other parts of East Asia dating back thousands of years.
Healthcare and Traditional Medicine Conferences are having the topics are Traditional Midwifery, Traditional African Medicine, Traditional Korean Medicine Acupuncture, Traditional Chinese Medicine, Islamic Medicine, Ancient Iranian Medicine, Siddha Medicine, Traditional Medicine Today: Clinical and Research Issues, Challenges and Future Directions of Traditional Medicine, Traditional Pharmaceuticals and Biologic Products, Herbalism
Cardiac imaging is visualization of the heart structure and cardiac blood flow for diagnostic evaluation or to guide cardiac procedures via techniques including Endoscopy, Radionuclide imaging, and Magnetic Resonance imaging, Tomography or Ultrasonography. Non-invasive cardiac imaging refers to a combination of methods that can be used to obtain images related to the structure and function of the heart. For invasive technique catheters are used to insert into the heart and this test is easy to perform and safe to detect various heart conditions .As a result of technological advances the number of available non-invasive cardiac tests that physicians can order has increased substantially over the last decade.
Echocardiography & Cardiac Imaging Events are covering the subjects are Strain Echocardiography, Focused Cardiac Ultrasound, Transthoracic Echocardiography, Doppler Echocardiography, Cardiovascular Magnetic Resonance/Cardiac MRI, Cardiac Imaging in Congenital Heart Diseases, Cardiac Angiography
Reduction Therapy Devices externally stimulate carotid baroreceptors, which are located within the carotid sinus in the neck, using our hand-held therapy device with our patented cold tip. Cold temperature stimulation of the baroreceptors, at a precise temperature and duration, results in modulating the autonomic nervous system, stimulating the parasympathetic nervous system, and lowering the sympathetic drive, causing vasodilation and lowering of the heart rate. The sum of these actions results in immediate lowering of blood pressure.
Cardiac Medications and Device Therapy Conferences are providing the topics are Blood Pressure Measuring Devices, Beta Blockers, Anticoagulants, Baroreflex Activation Therapy, Substantial placebo Effect of Device Therapy, Ambulatory Blood Pressure Monitoring, Transdermal Therapy of Hypertension, Baroreceptor Activation Therapy, Novel non-pharmacological Approaches, Cholesterol-lowering Drugs
Athletes with authorized cardiovascular disease or those at risk have particular goals and objectives in mind. They want to continue to play their sport and be very safe. The main aim of the Sports Cardiology Center is to work with any athlete forth the spectrum - professional athletes, recreational exercisers, to weekend warriors to help them reach these goals.
Sports Cardiology Congress covering the topics are Cardiovascular Assessment, Sports and Cardiovascular Disease, Cardiovascular Epidemiology & Population Science, Frequency and Causes of SCA in Young Athletes, Improving ECG Interpretation in Athletes, Patient-centered Counselling, Accurate Diagnosis and Treatment Plans, Sudden Cardiac Death in Sports
The prospective, randomized, clinical trial has been the foundation for evaluating the effectiveness of blood pressure-lowering drugs. The duration of clinical trials rarely exceeds five years, and trials focus on so-called “hard end points”—notably, all-cause mortality and/or cause specific morbidity and mortality due to CVD, usually coronary heart disease (CHD) and/or stroke, but more recently heart failure (HF) as well.
Case Presentations Meeting is has related areas are Integrating Lifestyle Advice into Clinical Management, Meta-Analysis of Blood Pressure-Lowering Drug Trials, Reporting Blood Pressure Parameters in Clinical Trials, Surrogate or Intermediate Disease Markers, Primary Biliary Cirrhosis
Hypertension Conference is glad to invite you to the upcoming International Conference on Hypertension & Cardiology planned to be held at Las Vegas, USA during September 3-4, 2018. The conference emphasizes the theme “Control Hypertension: Add life to Longevity”. Focusing on the latest ideas and advances for hypertension treatment and management. Hypertension Conference welcomes the innovative strategies in the area of hypertension research and also proposes a unique opportunity for the explorers from all over the world to gather, share and perceive new scientific interactions upon the various perceptions of hypertension.
Meetings Internationals organizes 150+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 150+ Open access journals which contains over 10000 eminent personalities, reputed scientists as editorial board members.
Hypertension Conference Highlights:
Important and scope:
Hypertension is a major risk factor for cardiovascular diseases, cerebrovascular events and ischaemic heart diseases, so is therefore one of the most important preventable causes of premature morbidity and mortality in developed and developing countries. It is often symptomless, so screening is vital before damage is done. Many surveys continue to show that hypertension remains underdiagnosed, undertreated and poorly controlled. Overall, the prevalence of hypertension (at least ≥140/90 mm Hg or on treatment) in those aged over 35 was observed to be 32% in men and 27% in women.
A prospective survey of patients in 20th century electrocardiography, preventive cardiology and the Framingham Study, lipid hypotheses and atherosclerosis, coronary care units, thrombolytic therapy, cardiac catheterization and coronary angiography, open-heart surgery, automatic implantable cardiac defibrillators, and coronary angioplasty. In hypertension, different changes made to the understand the basic levels of blood pressure and in the development of new diagnostic and therapeutic techniques.
Hypertension 2018 is an international platform for presenting research about Hypertension and related concepts, sharing alternative ideas about the severe cardiovascular risk factor, contributing to the dissemination of information about the trouble for the welfare of the society.
Overall Prevalence of Hypertension Globally:
Why Las Vegas?
Las Vegas officially the City of Las Vegas and often known simply as Vegas, is the 28th-most populated city in the United States, the most populated city in the state of Nevada, and the county seat of Clark County. The city anchors the Las Vegas Valley metropolitan area and is the largest city within the greater Mojave Desert. Las Vegas is an internationally renowned major resort city, known primarily for its gambling, shopping, fine dining, entertainment, and nightlife. The Las Vegas Valley as a whole serves as the leading financial, commercial, and cultural center for Nevada.
Why to attend?
Encounter the target market with members from across the globe, committed to learn about hypertension treatment and management. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations, distribute and update knowledge about the current situation of hypertension treatment and receive name recognition at this 2-day event. World-eminent speakers, most recent researches, latest treatment techniques and the advanced updates in Hypertension Treatment and Management are the principal features of this conference.
Our Organization would be privileged to welcome the: Directors of Hypertension or related Programs or Associations, Heads, Deans and Professors of Hypertension or Cardiology departments, Scientists and Researchers organizers, Doctors, Medical Colleges, Writers, Healthcare professionals, Founders and Employees of the related companies, Clinical investigators, Hospitals and Health Services, Pharmaceutical companies, Laboratory members, Training institutions, Support organizers, Data Management Companies, Cardiologists training and education, Nurse and nursing education institutions
Major Societies related to Hypertension:
Top Universities USA:
Hospitals Associated with Hypertension:
Industries Associated with Hypertension:
Market Growth of Hypertension Research in the last and upcoming Years:
Global Market at a Glimpse:
High blood pressure or hypertension is the most important risk factor for cardiovascular disease. In over 90% of cases there may be no identifiable cause of hypertension, in which case the condition is known as essential hypertension. The remaining 10% of cases, hypertension may be secondary in nature as a consequence of another medical problem, such as kidney disorders, adrenal tumours, or some drugs.
The prevalence of hypertension is forecasted to grow from 234 million in 2010 to 246 million in 2016 across the seven major markets (France, Germany, Italy, Spain, UK, US, and Japan). In 2016, the US is still expected to be the largest market for hypertension, with an anticipated 83 million sufferers, followed by Japan at 49 million. According to the International Society of Hypertension, there is a clear recognition of hypertension as a major public health issue across all the 7MM.
The global cardiovascular market recorded a sale of $170bn in the year 2010 and is set to grow to $187bn in 2016 at a CAGR of 1.6%. The US continued to be the largest market, with a share of 40% of the overall market. Antihypertensives remained the largest drug class in the year 2010, with a global sale of $37.6bn and a global market share of 22%.
Fund Allotment to Hypertension Research:
The NIH (National Institute of Health) Funding Opportunity Announcement (FOA), funded by the Patient-Centered Outcomes Research Institute (PCORI), funds up to two new patient-centred comparative effectiveness clinical trials, with the goal of comparing alternative, evidence-based ways to reduce inadequate control of hypertension and disparities in outcomes among high-risk populations, including racial/ethnic minority groups, patients with low socioeconomic status (SES), and individuals residing in rural geographical areas with an above average lifetime risk of cardiovascular disease (CVD). This initiative is supported by the Hypertension Disparities Reduction Program Partnership (HDRPP), a research partnership between NHLBI, NINDS and PCORI, with funds provided by PCORI to the NIH.
The fund allotment granted by the NIH is raised up to $21,500,000 worldwide for supporting research works associated with the advances in treatment and management of Hypertension.